F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 64 filers reported holding F-STAR THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 21.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $335,731 | +22.5% | 53,122 | -0.6% | 0.00% | – |
| Q3 2022 | $274,000 | -18.0% | 53,431 | 0.0% | 0.00% | – |
| Q2 2022 | $334,000 | +104.9% | 53,431 | +16.8% | 0.00% | – |
| Q1 2022 | $163,000 | -29.1% | 45,752 | 0.0% | 0.00% | – |
| Q4 2021 | $230,000 | -31.3% | 45,752 | 0.0% | 0.00% | – |
| Q3 2021 | $335,000 | -13.4% | 45,752 | +1.5% | 0.00% | – |
| Q2 2021 | $387,000 | – | 45,062 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 574,996 | $5,675,000 | 1.27% |
| Connolly Sarah T. | 53,001 | $523,000 | 0.48% |
| Endurant Capital Management LP | 20,445 | $202,000 | 0.07% |
| Private Capital Advisors, Inc. | 13,083 | $129,000 | 0.03% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 23,129 | $228,000 | 0.02% |
| Novo Holdings A/S | 34,819 | $344,000 | 0.02% |
| BVF INC/IL | 25,844 | $255,000 | 0.01% |
| TIEDEMANN ADVISORS, LLC | 17,243 | $170,000 | 0.01% |
| ARCADIA INVESTMENT MANAGEMENT CORP/MI | 3,000 | $30,000 | 0.01% |
| Renaissance Technologies | 181,789 | $1,794,000 | 0.00% |